Scientifically validated

Evidence 

Scientifically proven to kill pathogens and lower HCAI’s

Scientifically validated

Proven and tested

Independent labs have validated and certified the effectiveness of the T-1000 against a host of pathogens. All clinical studies showed positive results and confirmed the T-1000’s ability to inactivated pathogens. Peer-reviewed studies have also been conducted showing the effect UV-C disinfection has regarding healthcare-associated-infections (HCAI’s) reduction and disinfection within health care facilities.

Scientific research and evidence papers

Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection

William A. Rutala PhD, MPH, Hajime Kanamori MD, PhD, MPH, Maria F. Gergen MT (ASCP), Lauren P. Knelson MSPH, Emily E. Sickbert-Bennett PhD, MS, Luke F. Chen MBBS, MPH, MBA, Deverick J. Anderson MD, MPH, Daniel J. Sexton MD, David J. Weber MD, MPH and the CDC Prevention Epicenters Program

 

 

Rapid and complete inactivation of SARS-CoV-2 by ultraviolet-C irradiation

Nadia Storm, Lindsay McKay, Sierra Downs, Rebecca Johnson, Dagnachew Birru, Marc de Samber, Walter Willaert, Giovanni Cennini, Anthony Griffiths

 

Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design

Deverick J Anderson, MD, Rebekah W Moehring, MD, Prof David J Weber, MD, Sarah S Lewis, MD, Luke F Chen, MBBS, J Conrad Schwab, MD, Paul Becherer, MD, Michael Blocker, MD, Patricia F Triplett, MD, Lauren P Knelson, MSPH, Yuliya Lokhnygina, PhD, Prof William A Rutala, PhD, Prof Daniel J Sexton, MD

 

Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): a cluster-randomised, multicentre, crossover study

Dr Deverick J Anderson, MD, Dr Deverick J Anderson, Dr Deverick J Anderson, Luke F Chen, MBBS, Prof David J Weber, MD, Rebekah W Moehring, MD, Sarah S Lewis, MD, Patricia F Triplett, MD, Michael Blocker, MD, Paul Becherer, MD, J Conrad Schwab, MD, Lauren P Knelson, MSPH, Yuliya Lokhnygina, PhD, William A Rutala, PhD, Hajime Kanamori, MD, Maria F Gergen, MT ASCP, Prof Daniel J Sexton, MD for the CDC Prevention Epicenters Program

 

Deployment of a touchless ultraviolet light robot for terminal room disinfection: The importance of audit and feedback

Michele Fleming MSN, RN, CIC *, Amie Patrick BSN, RN, Mark Gryskevicz, Nadia Masroor MPH, BS, Lisa Hassmer MBA, Kevin Shimp MSN, RN, Kaila Cooper MSN, RN, CIC, Michelle Doll MD, MPH, Michael Stevens MD, MPH, Gonzalo Bearman MD, MPH

 

Implementation Lessons Learned From the Benefits of Enhanced Terminal Room (BETR) Disinfection Study: Process and Perceptions of Enhanced Disinfection with Ultraviolet Disinfection Devices

Deverick J. Anderson, MD;1 Lauren P. Knelson, MSPH;1 Rebekah W. Moehring, MD, MPH;1,3 Sarah S. Lewis, MD, MPH;1 David J. Weber, MD, MPH;2 Luke F. Chen, MBBS, MPH;1 Patricia F. Triplett, MD;2,4 Michael Blocker, MD;5,6 R. Marty Cooney, MPH, MSE, BSN;7 J. Conrad Schwab, MD;8 Yuliya Lokhnygina, PhD;9 William A. Rutala, PhD;2 Daniel J. Sexton, MD1 for the CDC Prevention Epicenters Program

 

science of UV-C Light 

shorter the wavelength the better

UV-C light is a subsection of the electromagnetic spectrum. It has the ability to destroy pathogens genetic make up by creating chemical reactions in their nucleic acids. This damages their RNA or DNA beyond repair making them longer infectious.